Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

NCT02709486 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

849

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Hip
Osteoarthritis, Knee

Interventions

DRUG: Tanezumab
DRUG: Tanezumab
DRUG: Placebo

Sponsor

Pfizer

Collaborators

[object Object]